Cyclobutanes - Therapeutic use
Research News and Information

Tuesday, March 16, 2010

Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene.

30 Aug 2009 The relationship between weight reduction after sibutramine treatment and a single nucleotide polymorphism, rs5443 (C825T), in the guanine nucleotide binding protein beta polypeptide 3 (GNB3) gene is currently inconsistent. In this study, we aimed ... Read more...

Immunotherapy for childhood warts.

29 Jun 2009 Treatment-resistant warts are a common and frustrating problem for patients, parents, and providers alike. No wart treatment is uniformly effective. Indeed, well-designed randomized controlled trials are sorely needed to establish the true efficacy ... Read more...

Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial.

16 Jun 2009 Low levels of bilirubin are associated with an increased risk of cardiovascular adverse events. Weight reduction is known to reduce several cardiovascular risk factors, but effects on bilirubin levels have not been reported. We studied the response ... Read more...

Latest indexed articles for 'Cyclobutanes - Therapeutic use'

These are the very latest articles for this heading:

• Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene. 30 Aug 2009
• Pharmacotherapy and surgery treatment for the severely obese adolescent. 29 Jun 2009
• Treatment of alopecia areata in children. 29 Jun 2009
• Immunotherapy for childhood warts. 29 Jun 2009
• Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial. 16 Jun 2009
• [Pharmaceutical treatment of binge eating disorder] 30 May 2009
• Sibutramine-induced recurrent seizures. 25 May 2009
• Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases. 26 Apr 2009
• Effect of sibutramine on weight reduction and insulin resistance in women with polycystic ovary syndrome. 9 Apr 2009
• Melanin-concentrating hormone-1 receptor antagonism and anti-obesity effects of ethanolic extract from Morus alba leaves in diet-induced obese mice. 16 Mar 2009
• Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis. 15 Mar 2009
• Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramine. 28 Feb 2009
• Medication update. 27 Feb 2009
• [Drug treatment of obesity] 27 Feb 2009
• Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trial. 15 Feb 2009
• Changes in symptoms of depression with weight loss: results of a randomized trial. 3 Feb 2009
• Sibutramine--its impact on health-related quality of life and depression among adult obese non-diabetic patients. 30 Dec 2008
• The use of sibutramine in the management of obesity and related disorders: an update. 30 Dec 2008
• Recent advances in obesity pharmacotherapy. 30 Dec 2008
• Pharmacotherapy for eating disorders and obesity. 30 Dec 2008

See a longer list of these articles.

Technical information about 'Cyclobutanes'

Registry Number: 0

Descriptor UI: D003503

Alternative terms: Cyclobutanes;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D02.455.426.392.368.201;

History Note: 74(72)

Technical Notes: includes cyclobutenes